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Introduction. During the past decade, novel techniques of corneal transplantation allowing faster and better restoration of vision have
emerged. +e present cohort study describes a shift of indications and techniques that has occurred in the ﬁeld of corneal
transplantation over a 17-year period in Greece.Methods. All patients undergoing keratoplasty between January 1999 and December
2015 at an academic tertiary referral center in Athens, Greece, were retrospectively reviewed. +e annual incidence of keratoplasty
indications and techniques was recorded and analyzed. Results. A total of 1382 keratoplasty procedures were included. Leading
indications were bullous keratopathy (BK) (37.5%), followed by allograft rejection (17.7%), corneal scar (12%), keratoconus (KC)
(10.3%), and Fuchs endothelial dystrophy (FED) (8.8%). A decreasing trend was observed for KC (P � 0.009) and an increasing trend
for BK (P � 0.003) and FED (P � 0.001). In 2015, the incidence of penetrating keratoplasty (PK) had decreased from 100% (1999 to
2009) to 21.4%; for cases with isolated pathology of the corneal endothelium, DSAEK was the preferred technique (59.8%), while the
respective rate of DMEK was 18.8%. Conclusion. Herein, we observed an increasing trend of endothelial pathology among ker-
atoplasty indications as well as a major shift in preferred techniques due to a wide adoption of the new EK procedures.
1. Introduction
Keratoplasty is one of the most common and successful
allotransplantations in humans and the only treatment of
several corneal pathologies. Since the ﬁrst successful cor-
neal transplantation by Zirm in 1906 [1], penetrating
keratoplasty (PK) was the gold standard. Over the past de-
cade, however, advancements in the ﬁeld of corneal trans-
plantation changed the preferred practice patterns of corneal
surgeons.+emore or less selective transplantation of corneal
endothelium evolved since the introduction of posterior la-
mellar keratoplasty in 1998 [2] to safer and more targeted
techniques, for example, Descemet (automated) stripping
endothelial keratoplasty (DS(A)EK) [3] and Descemet
membrane endothelial keratoplasty (DMEK) [4, 5]. More-
over, advancements in the ﬁeld of keratoconus surgery that
may delay or even arrest disease progression, that is,
corneal crosslinking (CXL), have reduced the need for
keratoplasty [6].
Indeed, recent reports describe both an increase of en-
dothelial pathology and a shift from PK to lamellar kerato-
plasty techniques [7–9]. However, only limited data on the
implementation of DMEK among keratoplasty procedures are
available [8, 9]. Purpose of the current paper is therefore to
report trends in indications and techniques in a cohort where
both DMEK and DSAEK were implemented.
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2. Materials and Methods
+e records of all corneal transplantations conducted be-
tween 1999 through 2015 at a referral center in a large
hospital in Athens, Greece (First Department of Ophthal-
mology, National and Kapodistrian University, Athens, and
Ophthalmology Department, General Hospital “G. Genni-
matas”) were reviewed.
All procedures were performed by 3 surgeons in total.
+e number of surgeons operating during each calendar year
varied from 1 to 3.
+e present research adhered to the tenets of the Dec-
laration of Helsinki. Due to the observational and retro-
spective character of the study, IRB approval was not
required.
2.1. Data Collection. Indications were grouped according to
the following criteria:
(1) “Bullous keratopathy” (BK) included all cases of
corneal endothelial decompensation except for cases
of Fuchs endothelial dystrophy and failed corneal
grafts.
(2) “Regraft” included cases of repeat keratoplasty due to
graft failure.
(3) “Corneal scar” included stromal opacities, for example,
after herpetic and infectious keratitis, pemphigoid,
chemical and mechanical trauma, trachoma, or anes-
thetic abuse.
(4) “Keratoconus” (KC).
(5) “Fuchs endothelial dystrophy” (FED).
(6) “Sterile melt/perforation” included all cases of non-
infectious keratitis leading to corneal perforation.
(7) “Infectious keratitis” included all cases of therapeutic
keratoplasty for progressive corneal melt due to bac-
teria, fungi, or acanthameba. +is group also included
cases where the pathogen could not be isolated.
(8) “Stromal dystrophies” (SD).
2.2. Statistical Analysis. All data were collected with Excel
software (version 14, Microsoft Corp.). Descriptive and
inferential data analysis was performed with SPSS software
(version 17.0, SPSS Inc.). Numerical data are presented as
mean± standard deviation. Evolution of recipient age,
gender, and surgical indication were assessed using linear
regression analysis. +e x2 test was used where appropriate.
A P value less than 0.05 was considered statistically
signiﬁcant.
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Figure 1: Chart depicting distribution of recipient age (a) and gender distribution (b) per calendar year. (a) Recipient age shows
a statistically signiﬁcant increase (P< 0.001, r2 � 0.79, univariate linear regression). (b) In addition, a switch from male to female pre-
dominance is noted in 2009, the year of EK implementation. +is also may be explained by the increase Fuchs endothelial dystrophy that
aﬀects mainly women.
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3. Results
3.1. Demographics. +e present retrospective cohort study
includes 1382 eyes undergoing corneal transplantation at
a single tertiary referral center with a nationwide patient
pool. While the majority of donor tissue (79.4%) was im-
ported from eye banks outside Greece, the rest was retrieved
from local multiorgan donors.
Mean recipient age was 61.9 ± 5.1 years with increasing
trend, starting at 53.3± 20.7 years (1999) and reaching
71.1± 12.0 years (2015) (P< 0.001, r2 � 0.79, univariate
linear regression) (Figure 1(a)).
+e present cohort comprises 736 men (53.3%) and 646
women (46.7%) in total. In 2009, a switch of male to female
predominance was evident, suggesting an increasing trend
for female patients. Indeed, when dividing the observation
time into a ﬁrst (1999 through 2008) and last period (2009
through 2015), an increasing trend for females was found
only in the last period (P � 0.011, r2 � 0.89, univariate
linear regression) (Figure 1(b)).
Patients with keratoconus (KC, mean age 36.1± 14.3
years) formed the youngest and patients with BK the oldest
group (mean age 71.2± 11.5 years) (Figure 2(a)). A sig-
niﬁcant predominance of men was found in KC
(x2 � 13.36, P< 0.001), regraft (x2 � 7.55, P � 0.006), and
scar (x2 � 20.27, P< 0.001), while that of women was found
in FED (x2 � 11.84, P � 0.001) (Figure 2(b)).
3.2. Indications. Leading indication was BK (37.5%), fol-
lowed by allograft rejection (17.7%), corneal scar (12%), KC
(10.3%), FED (8.8%), corneal melt (5.8%), infectious keratitis
(5.7%), and stromal dystrophy (2.2%) (Figure 3).
Univariate linear regression analysis of the annual incidence
for each indication revealed a signiﬁcant increase of endothelial
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Figure 2: Chart depicting recipient age (a) and gender distribution (b) per indication. (a) +e lowest age is observed in keratoconus while
the highest in Fuchs endothelial dystrophy patients. (b) Signiﬁcant predominance of men is noted in keratoconus (65.5%) and corneal scar
(67.5%) whereas of women in Fuchs endothelial dystrophy patients (65.6%).
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Figure 3: +e pie chart illustrates the incidence of all keratoplasty
indications from 1999 to 2015. Top 3 indications were bullous
keratopathy (37.5%), regraft (17.7%), and corneal scar (12%). Each
diagnosis is represented by the same color as in the bar chart in
Figure 2.
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pathologies, that is, BK (r2 � 0.47, P � 0.003) and FED
(r2 � 0.55, P � 0.001) and a signiﬁcant decrease in corneal
scar (r2 � 0.72, P< 0.001) and KC (r2 � 0.38, P � 0.009). All
other indications did not show signiﬁcant ﬂuctuations (uni-
variate linear regression analysis) (Figure 4).
3.3. Techniques. PK was the only technique applied until
2009, when DSAEK was introduced, starting with 8.9%
(2009) and reaching 59.9% (2015) (Figure 5). DMEK was
introduced in July 2013 reaching 11.8% in the ﬁrst (half )
year, peaking with 41.5% in the second year, and decreasing
to 18.8% in the third year of its implementation (Figure 5).
By the ﬁnal year of the study, EK was the preferred
treatment for BK (89.8% EK versus 11.2% PK) and the only
treatment for FED (Figure 6).
4. Discussion
+e present study reports trends in keratoplasty indications
and techniques from 1999 through 2015 at an academic
tertiary referral center in Athens, Greece. As part of this
study, the implementation of new endothelial keratoplasty
techniques (DMEK and DSAEK) in a large keratoplasty
cohort was evaluated.
+e leading indication herein was BK (37.7%), being in
accordance with a previous Greekmulticenter study reporting
aphakic/pseudophakic corneal edema (29.1%), keratoconus
(26%), and regraft (11.9%) as main indications [10].
+e increase of corneal endothelial pathology (BK and
FED) among indications may be explained by the early and
successful adoption of DSAEK and DMEK in our cohort
(Figure 4).
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Figure 4: Scatter plot depicting the annual incidence of each keratoplasty indication. A signiﬁcant trend was found for bullous keratopathy
(BK; r2 � 0.47, P � 0.003), corneal scar (r2 � 0.72, P< 0.001), keratoconus (KC; r2 � 0.38, P � 0.009), and Fuchs endothelial dystrophy
(FED; r2 � 0.55, P � 0.001). All others were found not signiﬁcant (univariate linear regression analysis).
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Figure 5: Column chart depicting the absolute number of keratoplasty procedures performed in each calendar year from 1999 to 2015.
Penetrating keratoplasty (gray columns) was the only technique applied until DSAEK (green columns) and DMEK (red columns) were
implemented (2009 and 2013, resp.). In the last year, PK was only performed in 21.4%. Signiﬁcant ﬂuctuations in the annual number of
surgeries were caused by ﬂuctuations in the number of operating surgeons as well as by graft shortage periods.
0
20
40
60
80
100
PK
DSAEK
DMEK
19
99
20
00
20
01
20
02
20
03
20
04
20
05
20
06
20
07
20
08
20
09
20
10
20
11
20
12
20
13
20
14
20
15
(%)
(a)
19
99
20
00
20
01
20
02
20
03
20
04
20
05
20
06
20
07
20
08
20
09
20
10
20
11
20
12
20
13
20
14
20
15
PK
DSAEK
DMEK
0
20
40
60
80
100
(%)
(b)
Figure 6: Continued.
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On the other hand, KC demonstrated a signiﬁcant de-
crease over time that may relate to the introduction of CXL
as well as advancements in optical rehabilitation, for ex-
ample, scleral contact lenses or intracorneal ring segments.
Compared to the global introduction of new lamellar
techniques [7], the present cohort keeps up with advance-
ments in endothelial keratoplasty. +us, although it took
three years for EK (DSAEK) to surpass PK, both EK tech-
niques (DSAEK and DMEK) were successfully imple-
mented, with EK accounting for 78.6% of the total
keratoplasty procedures performed during the ﬁnal year of
our study (Figure 5). +is is in agreement with other studies
reporting similar trends in keratoplasty techniques [7–9].
With regard to endothelial pathology, EK procedures have
almost completely replaced PK, ranging between 88.9% for
BK and 100% for FED cases (Figure 6).
+is rapid shift in surgeons’ preferences from PK to EK
techniques in the treatment of endothelial pathology can
easily be explained by several advantages of EK, for example,
smaller incisions, fewer or no sutures, and no open sky
surgery. +e main advantage of EK however is faster and
better visual rehabilitation and lower risk for immunologic
rejection [8, 11, 12].
Another notable observation is the smooth imple-
mentation of DMEK accounting for 36% of EK procedures
during the last 3 years of the study, as opposed to a peak rate
of 11% for 2014, as recently reported by the Eye Bank
Association of America [7].
In conclusion, keratoplasty indications showed remarkable
trends over the past 17 years. +ese changes relate to the in-
troduction of endothelial keratoplasty as well as to new
treatment alternatives for KC other than keratoplasty. Re-
spectively, a considerable shift of keratoplasty techniques from
PK to DSAEK and DMEK in the treatment of endothelial
disorders is evident. Finally, despite being a challenging pro-
cedure, DMEK was successfully implemented in our center.
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